<DOC>
	<DOCNO>NCT01143844</DOCNO>
	<brief_summary>Hypothesis : Girls woman expose chemotherapy and/or radiation therapy experience endocrine change similar woman late reproductive year same-age peer . These change dramatic woman receive high dose therapy compare woman receive low dose therapy . At annual visit 3-5 year , combination physical exam , medical history , menstrual diary keep , pelvic ultrasound blood hormone test use measure `` ovarian reserve '' , number quality egg remain ovary . The study also try learn receive high dos certain chemotherapy likely change test sooner woman receive small dos drug . Additionally DNA ( deoxyribonucleic acid ) sample collect look gene variation may predict susceptibility ovarian damage cancer treatment . Information learn study may help researcher develop guideline identify problem female cancer survivor 's ovary irregular menses symptom ovarian failure occur .</brief_summary>
	<brief_title>Assessing Fertility Potential Female Cancer Survivors</brief_title>
	<detailed_description>Up 400 female participate study one three cohort : - 150 female age 11-35 , history exposure alkylating agent chemotherapy and/or radiation therapy - 150 Unexposed peer , age 11-35 , never expose chemotherapy radiation therapy - 100 Unexposed female , age 40-50 never expose chemotherapy radiation therapy</detailed_description>
	<criteria>Inclusion Criteria cancer survivor : Previous treatment chemotherapy and/or radiation therapy either cancer another illness . Age 1135 year . Postmenarchal . Presence uterus least one ovary . Ability willingness comply study protocol . Have give write informed consent , prior studyrelated procedure , part normal medical care , understand consent may withdraw patient time without prejudice future medical care . Inclusion Criteria control : Healthy female never treat cancer . Age 1135 4050 year . Postmenarchal regular cyclic menses ( every 2135 day ) Presence uterus least 1 ovary . Ability willingness comply study protocol . Have give write informed concent , prior studyrelated procedure , part normal medical care , understand consent may withdraw patient time without prejudice future medical care . Current pregnancy . Use hormonal contraception use hormone replacement therapy within previous 4 week . Lactation within previous 3 month . Chronic illness would limit ability participant comply study protocol . Any known medical condition , cancer , judgement investigator know associated premature ovarian failure ( Turner 's Syndrome Fragile X ) ovulatory dysfunction ( thyroid disease , adrenal dysfunction , Cushing 's syndrome , hyperprolactinemia , polycystic ovarian syndrome ) . For control , history infertility .</criteria>
	<gender>Female</gender>
	<minimum_age>11 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Oncofertility</keyword>
	<keyword>Fertility</keyword>
	<keyword>Late effect</keyword>
	<keyword>cancer</keyword>
	<keyword>chemotherapy</keyword>
	<keyword>radiation therapy</keyword>
	<keyword>survivor</keyword>
	<keyword>ovarian reserve</keyword>
	<keyword>premature ovarian failure</keyword>
	<keyword>early menopause</keyword>
	<keyword>healthy volunteer</keyword>
	<keyword>perimenopause</keyword>
	<keyword>middle age</keyword>
	<keyword>pediatric survivor</keyword>
	<keyword>healthy woman</keyword>
</DOC>